The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (Sprit)

This study is currently recruiting participants.
Verified March 2012 by Chinese Medical Doctor Association
Sponsor:
Information provided by (Responsible Party):
Lin Shen,MD & Ruihua Xu,MD、PhD, Chinese Medical Doctor Association
ClinicalTrials.gov Identifier:
NCT01549067
First received: March 6, 2012
Last updated: March 13, 2012
Last verified: March 2012

March 6, 2012
March 13, 2012
September 2011
December 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01549067 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Collect the real clinical background of advanced colorectal cancer c of China.

The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.

Observational
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Advanced Colorectal Cancer

  • Advanced Malignant Neoplasm
  • Colorectal Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
3700
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.

Exclusion Criteria:

  • Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.
Both
Not Provided
No
Contact: Lin Shen, MD 010-88140650 lin100@medmail.com.cn
Contact: Rui-hua Xu, MD , PhD 020-87343468 xurh@sysucc.org.cn
China
 
NCT01549067
Sprit
Yes
Lin Shen,MD & Ruihua Xu,MD、PhD, Chinese Medical Doctor Association
Chinese Medical Doctor Association
Not Provided
Principal Investigator: Lin Shen, MD Peking University Cancer Hospital
Principal Investigator: Ruihua Xu, MD, PhD Sun Yat-sen University
Chinese Medical Doctor Association
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP